Table 2.
Visit-wise mean GDS scores for all participants (N) with number (%) significant depressive symptoms by group
| All participants | Celecoxib | Naproxen | Placebo | |||||
|---|---|---|---|---|---|---|---|---|
| Visit | N (%) | Mean GDS (sd) |
N (%) | Mean GDS (sd) |
N (%) | Mean GDS (sd) |
N (%) | Mean GDS (sd) |
| EN | 2311 (19.43) | 3.29 (3.33) | 669 (19.88) | 3.38 (3.59) | 656 (18.90) | 3.19 (3.17) | 986 (19.47) | 3.30 (3.25) |
| F12 | 2233 (22.84) | 3.57 (3.61) | 650 (23.69) | 3.81 (3.88) | 633 (23.38) | 3.53 (3.38) | 950 (21.89) | 3.43 (3.56) |
| F24 | 2044 (23.34) | 3.67 (3.69) | 600 (22.67) | 3.72 (3.75) | 577 (24.09) | 3.71 (3.87) | 867 (23.3) | 3.60 (3.52) |
| F36 | 1659 (25.80) | 3.84 (3.82) | 467 (26.77) | 4.00 (3.93) | 477 (26.42) | 3.81 (3.79) | 715 (24.76) | 3.75 (3.77) |
| F48 | 1080 (27.22) | 4.09 (3.97) | 310 (30.65) | 4.20 (4.11) | 310 (24.84) | 4.08 (4.03) | 460 (26.52) | 4.02 (3.85) |
| F60 | 323 (25.39) | 3.90 (3.95) | 94 (26.60) | 3.73 (3.91) | 88 (27.27) | 4.15 (3.96) | 141 (23.40) | 3.85 (4.01) |